Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
D0Q3SP
|
||||
| Former ID |
DIB009504
|
||||
| Drug Name |
NPS-1392
|
||||
| Indication | Cerebrovascular ischaemia [ICD9: 434.91; ICD10:I61-I63] | Terminated | [1] | ||
| Company |
NPS Pharmaceuticals Inc
|
||||
| Structure |
|
Download2D MOL |
|||
| Canonical SMILES |
c1(C(c2cc(F)ccc2)[C@H](CN)C)cc(F)ccc1
|
||||
| CAS Number |
CAS 170018-66-3
|
||||
| Target and Pathway | |||||
| Target(s) | NMDA receptor | Target Info | Antagonist | [2] | |
| References | |||||
| REF 1 | Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800013127) | ||||
| REF 2 | Synthesis, biological activity, and absolute stereochemical assignment of NPS 1392: a potent and stereoselective NMDA receptor antagonist. Bioorg Med Chem Lett. 1999 Jul 19;9(14):1915-20. | ||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.